The global scar treatment market size is expected to reach USD 4.94 billion by 2030, registering a CAGR of 11.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. Scar treatment market is developing at a fast rate due to the growing awareness among people regarding aesthetics.
The appearance of different types of scars poses a huge challenge to the day-to-day lifestyle of victims while affecting their aesthetic appeal. Hence, this factor is expected to develop an increased need for scar treatment. Acne scars are one of the most common concerns for women, which disrupt their aesthetic appeal, making them uncomfortable. Consequently, the demand for scar treatment products is expected to rise, owing to the growing concern for aesthetics.
The aesthetic industry witnessed significant setbacks due to the COVID-19 pandemic in the second and third quarters of 2020. Since the majority of procedures were not medical necessities, lockdowns in several countries led to the closure of beauty clinics, med spas, dermatology clinics, and retail stores. However, online consultancy helps patients overcome these problems.
The increasing number of road accidents globally continues to lead to several face and body marks, which frequently need surgical treatment. As a result, patients who have undergone such procedures are usually given topical scar reduction products. Cosmetic surgeries using laser instruments are also gaining popularity to treat severe road accident scars. A victim's daily life is hampered by post-burn marks. Plastic surgeries or resurfacing laser therapies are being used to remove these marks.
Scar removal products that are technologically advanced are widely available on the market, which reduces pain and makes scar treatment a simple process. For instance, UltraPulse by Lumenis uses CO2 laser to treat acne scars, which reduces the risk of pain during the treatment process.
Request a free sample copy or view the report summary: Scar Treatment Market Report
By product, the topical products segment held the largest market share of 65.7% in 2024.The laser products segment is witnessing significant growth at a CAGR of 12.2% during the forecast period.
By scar type, the atrophic scars segment held the largest market share of 37.1% in 2024 due to the rising prevalence of acne scars.The hypertrophic and keloid scars segment is witnessing a significant CAGR during the forecast period.
By end-use,the homecare segment dominated the market with the largest revenue share of 65.7% in 2024. The clinics segment is expected to witness lucrative growth during the forecast period.
Asia Pacific’s scar treatment market held the largest share of 39.8% of the global market in 2024. The scar treatment market in Japan is driven by factors such as growing emphasis on aesthetic appearance, an aging population in Japan, and advancements in scar treatment technologies.
Grand View Research has segmented global scar treatment market report based on product, scar type, end-use, and region:
Scar Treatment Product Outlook (Revenue, USD Million, 2018 - 2030)
Topical Products
Creams
Gels
Silicon Sheets
Others
Laser Products
CO2 Laser
Pulse-dyed Laser
Others
Injectables
Others
Scar Treatment Scar Type Outlook (Revenue, USD Million, 2018 - 2030)
Atrophic Scars
Hypertrophic & Keloid Scars
Contracture Scars
Stretch Marks
Scar Treatment End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Clinics
Homecare
Scar Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
Spain
France
Italy
Russia
Denmark
Norway
Sweden
Asia Pacific
China
India
Japan
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Scar Treatment Market
Smith & Nephew PLC
Lumenis
Merz Pharmaceuticals, LLC
Sonoma Pharmaceuticals, Inc.
Cynosure
CCA Industries, Inc.
Newmedical Technology Inc.
Mölnlycke Health Care AB
Suneva Medical
Scar Heal Inc.
Pacific World Corporation
Perrigo Company plc
Enaltus LLC
"The quality of research they have done for us has been excellent..."